Bionomics Limited (NASDAQ: BNOX)
$0.77
+0.0036 ( +0.47% ) 39.8K
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Market Data
Open
$0.77
Previous close
$0.77
Volume
39.8K
Market cap
$10.59M
Day range
$0.75 - $0.79
52 week range
$0.65 - $6.41
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 16, 2024 |
3 | Insider transactions | 1 | Jul 12, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
3 | Insider transactions | 1 | Jul 08, 2024 |
6-k | Quarterly Reports | 6 | Jun 03, 2024 |
6-k | Quarterly Reports | 9 | Mar 15, 2024 |